Patent details
EP1763356 Title: COMPOSITION COMPRISING A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND GEMCITABINE FOR THE TREATMENT OF CANCER
Basic Information
- Publication number:
- EP1763356
- PCT Application Number:
- PCT/US/2005/012968
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP057383077
- PCT Publication Number:
- WO/2005/107771
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMPOSITION COMPRISING A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND GEMCITABINE FOR THE TREATMENT OF CANCER
- French Title of Invention:
- COMPOSITION COMPRENANT UN OLIGONUCLEOTIDE SURVIVIN ANTISENS ET GEMCITABINE POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- ZUSAMMENSETZUNG MIT EINEM SURVIVIN-ANTISENSE-OLIGONUCLEOTID UND GEMCITABIN ZUR BEHANDLUNG VON KREBS
- SPC Number:
Dates
- Filing date:
- 15/04/2005
- Grant date:
- 16/07/2008
- EP Publication Date:
- 16/07/2008
- PCT Publication Date:
- 17/11/2005
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/03/2007
- EP B1 Publication Date:
- 16/07/2008
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/04/2013
- Expiration date:
- 15/04/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/04/2005
- Name:
- ELI LILLY AND COMPANY
- Address:
- Lilly Corporate Center, Indianapolis, Indiana 46285, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 16/07/2008
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- PATEL Bharvin, Kumar
- Address:
- United States (US)
Priority
- Priority Number:
- 564540 P
- Priority Date:
- 22/04/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/7088;
| Filing date | Document type | Number of pages |
|---|